206 related articles for article (PubMed ID: 20434879)
1. Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study.
Bellavia D; Pellikka PA; Al-Zahrani GB; Abraham TP; Dispenzieri A; Miyazaki C; Lacy M; Scott CG; Oh JK; Miller FA
J Am Soc Echocardiogr; 2010 Jun; 23(6):643-52. PubMed ID: 20434879
[TBL] [Abstract][Full Text] [Related]
2. Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study.
Bellavia D; Pellikka PA; Dispenzieri A; Scott CG; Al-Zahrani GB; Grogan M; Pitrolo F; Oh JK; Miller FA
Eur Heart J Cardiovasc Imaging; 2012 Aug; 13(8):680-9. PubMed ID: 22307866
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
Buss SJ; Emami M; Mereles D; Korosoglou G; Kristen AV; Voss A; Schellberg D; Zugck C; Galuschky C; Giannitsis E; Hegenbart U; Ho AD; Katus HA; Schonland SO; Hardt SE
J Am Coll Cardiol; 2012 Sep; 60(12):1067-76. PubMed ID: 22883634
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
Koyama J; Falk RH
JACC Cardiovasc Imaging; 2010 Apr; 3(4):333-42. PubMed ID: 20394893
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.
Salinaro F; Meier-Ewert HK; Miller EJ; Pandey S; Sanchorawala V; Berk JL; Seldin DC; Ruberg FL
Eur Heart J Cardiovasc Imaging; 2017 Sep; 18(9):1057-1064. PubMed ID: 27965280
[TBL] [Abstract][Full Text] [Related]
7. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
[TBL] [Abstract][Full Text] [Related]
8. Pericardial Effusion and Multiple Organ Involvement Are Independent Predictors of Mortality in Patients with Systemic Light Chain Amyloidosis.
Yuda S; Hayashi T; Yasui K; Muranaka A; Ohnishi H; Hashimoto A; Ishida T; Tsuchihashi K; Shinomura Y; Watanabe N; Miura T
Intern Med; 2015; 54(15):1833-40. PubMed ID: 26234222
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
[TBL] [Abstract][Full Text] [Related]
10. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis.
Migrino RQ; Mareedu RK; Eastwood D; Bowers M; Harmann L; Hari P
J Am Soc Echocardiogr; 2009 Dec; 22(12):1396-402. PubMed ID: 19880277
[TBL] [Abstract][Full Text] [Related]
12. Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity of Disease and Prognosis in Light-Chain Amyloidosis.
Wan K; Sun J; Yang D; Liu H; Wang J; Cheng W; Zhang Q; Zeng Z; Zhang T; Greiser A; Jolly MP; Han Y; Chen Y
Radiology; 2018 Jul; 288(1):73-80. PubMed ID: 29664336
[TBL] [Abstract][Full Text] [Related]
13. Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis.
Apridonidze T; Steingart RM; Comenzo RL; Hoffman J; Goldsmith Y; Bella JN; Landau H; Liu JE
Am J Cardiol; 2012 Oct; 110(8):1180-4. PubMed ID: 22770934
[TBL] [Abstract][Full Text] [Related]
14. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography.
Bellavia D; Abraham TP; Pellikka PA; Al-Zahrani GB; Dispenzieri A; Oh JK; Bailey KR; Wood CM; Novo S; Miyazaki C; Miller FA
J Am Soc Echocardiogr; 2007 Oct; 20(10):1194-202. PubMed ID: 17596912
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis.
Briasoulis A; Bampatsias D; Petropoulos I; Rempakos A; Patras R; Theodorakakou F; Makris N; Dimopoulos MA; Stamatelopoulos K; Kastritis E
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):698-707. PubMed ID: 38142437
[TBL] [Abstract][Full Text] [Related]
16. Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis.
Mohty D; Pibarot P; Dumesnil JG; Darodes N; Lavergne D; Echahidi N; Virot P; Bordessoule D; Jaccard A
Arch Cardiovasc Dis; 2011 Dec; 104(12):611-8. PubMed ID: 22152513
[TBL] [Abstract][Full Text] [Related]
17. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography.
Bellavia D; Pellikka PA; Abraham TP; Al-Zahrani GB; Dispenzieri A; Oh JK; Bailey KR; Wood CM; Lacy MQ; Miyazaki C; Miller FA
Am J Cardiol; 2008 Apr; 101(7):1039-45. PubMed ID: 18359328
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
[TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
[TBL] [Abstract][Full Text] [Related]
20. Doppler myocardial imaging compared to standard two-dimensional and Doppler echocardiography for assessment of diastolic function in patients with systemic amyloidosis.
Al-Zahrani GB; Bellavia D; Pellikka PA; Dispenzieri A; Hayman SR; Oh JK; Miyazaki C; Miller FA
J Am Soc Echocardiogr; 2009 Mar; 22(3):290-8. PubMed ID: 19121568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
